Skip to content
Governance Register

← US public companies

In8BIO, INC.

SEC CIK 1740279 · [INAB · last insider filing 2026-05-29

Directors (from insider filings)

NameCapacity as filedFilings
Fairbairn Emily Director filed 2021 - 2026
Brandt Peter C. Director filed 2021 - 2026
Ho William Tai-Wei Director · President, CEO and CFO filed 2021 - 2026
Epperly Corinne Director filed 2023 - 2026
Greenwood Luba Director filed 2021 - 2026
Graff Jeremy R. Director filed 2023 - 2026
Roemer Alan S. Director filed 2021 - 2025
Bios Fund II, LP Director filed 2021 - 2025
Bios Fund II QP, LP Director filed 2021 - 2025
Bios Fund II NT, LP Director filed 2021 - 2025
Bios Incysus Co-Invest I, LP Director filed 2021 - 2025
Fletcher Aaron G.L. Director filed 2021 - 2025
Bios Fund III NT, LP Director filed 2021 - 2025
Bios Fund III QP, LP Director filed 2021 - 2025
Bios Fund III, LP Director filed 2021 - 2025
Cavu Management, LP Director filed 2021 - 2025
Cavu Advisors, LLC Director filed 2021 - 2025
Bios Equity Partners II, LP Director filed 2021 - 2025
Kreis Leslie W. Director filed 2021 - 2025
Bios Advisors GP, LLC Director filed 2021 - 2025
Bios Capital Management, LP Director filed 2021 - 2025
Bios Equity Partners III, LP Director filed 2021 - 2025
Whitfill Travis Director filed 2021 - 2024

Officers (from insider filings)

NameTitle as filedFilings
Lamb Lawrence EVP and CSO filed 2021 - 2026
Mccall Patrick Chief Financial Officer filed 2021 - 2026
Rochlin Kate President and COO filed 2021 - 2026
Goswami Trishna Chief Medical Officer filed 2021 - 2024
Beelen Melissa VP, Clinical Operation filed 2021 - 2021

About this record

From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.

Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.